• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

Cancer Screening In Symptomatic Patients Using Pap Smear Test- A Hospital Based Study

    Dr.Bhawana Bansal, Dr. SanjeevNarang, Dr. Anjali Singh, Dr. Rahul Karode, Dr.ParulMaheshwari

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2558-2564

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Cervical carcinoma is second most common cancer in India and a major
cause of death among women.Timely diagnosis and treatment allow significant reduction
of morbidity and mortality.The present study is an attempt to screen women attending
Gynaecology OPD at Index Medical College Indore for the cervical cancer using Pap
smear studies.
Objective: To evaluate the use of Pap smear screening method for detection of precancerous
lesions of the uterine cervix.
Methodology: In this study 110 women attending the Gynae OPD with complaints of
abdominal pain, irregular menses, discharge PV and post-coital pain or bleeding were
included. Pap smear was taken after history taking and clinical examination for all women
to screen the cervical cancer. Smear stained with Papanicolaou stain and studied in the
Department of Pathology.
Results: In the study, most women were in the age range of 21 to 50 years and
multiparous.Vaginal discharge was the chief complaint,followed by irregular menses and
lower abdominal pain .After Pap smear study,the test was negative for malignancy in 23 %
of women, 40% of women had bacterial vaginosis and 18% diagnosed as having
candidiasis.ASC-US, ASC-H, LSIL and HSIL were detected in 5.5%, 2%, 5.5% and 2 % of
women respectively.Women with ASC-US, ASC-H, LSIL, HSILunderwent colposcopy and
biopsy.
Conclusion: Pap smear is a simple, non-invasive, cost-effective, highly sensitive and
specific method for diagnosing precancerous lesions of cervix.By instituting a well-planned
screening program, cervical cancer related morbidity and mortality can be reduced
Keywords:
    ASCUS LSIL HSIL NILM Bacterial Vaginosis Papanicolaou stain
  • PDF (366 K)
  • XML
(2022). Cancer Screening In Symptomatic Patients Using Pap Smear Test- A Hospital Based Study. European Journal of Molecular & Clinical Medicine, 8(4), 2558-2564.
Dr.Bhawana Bansal, Dr. SanjeevNarang, Dr. Anjali Singh, Dr. Rahul Karode, Dr.ParulMaheshwari. "Cancer Screening In Symptomatic Patients Using Pap Smear Test- A Hospital Based Study". European Journal of Molecular & Clinical Medicine, 8, 4, 2022, 2558-2564.
(2022). 'Cancer Screening In Symptomatic Patients Using Pap Smear Test- A Hospital Based Study', European Journal of Molecular & Clinical Medicine, 8(4), pp. 2558-2564.
Cancer Screening In Symptomatic Patients Using Pap Smear Test- A Hospital Based Study. European Journal of Molecular & Clinical Medicine, 2022; 8(4): 2558-2564.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 121
  • PDF Download: 102
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus